Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 21, 2014; 20(31): 10984-10993
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10984
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10984
Table 6 Multivariate logistic regression for fibrosis, age and ribavirin/peg-interferon adverse events as factors for sustained virological response
| Sig. | Exp (B) | 95%CI for EXP(B) | ||
| Lower | Upper | |||
| Fibrosis stage F4 vs Fibrosis stage F0, F1, F2, F3 | 0.004 | 0.717 | 0.573 | 0.897 |
| Age 60 yr vs < 60 yr | 0.003 | 0.427 | 0.243 | 0.750 |
| Treatment discontinuation due to ribavirin adverse events | 0.142 | |||
| Treatment discontinuation due to Peg-IFN adverse events | 0.998 | |||
- Citation: Roeder C, Jordan S, Schulze zur Wiesch J, Pfeiffer-Vornkahl H, Hueppe D, Mauss S, Zehnter E, Stoll S, Alshuth U, Lohse AW, Lueth S. Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection. World J Gastroenterol 2014; 20(31): 10984-10993
- URL: https://www.wjgnet.com/1007-9327/full/v20/i31/10984.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i31.10984